Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05085704 · ClinicalTrials.gov registry record
Brain Metabolism Observed at 7 Tesla
A clinical trial of Epilepsy and Glucose Metabolism Disorders, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05085704 is a study of Epilepsy and Glucose Metabolism Disorders that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 20 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05085704, a study of Epilepsy and Glucose Metabolism Disorders, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal is to develop methodology to monitor flux in the citric acid cycle in brain via 13C nuclear magnetic resonance (NMR) spectroscopy at 7 Tesla.
Conditions Studied
Interventions
- DEVICE Magnetic resonance imaging
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-05-03 |
| Est. Completion | 2026-09-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05085704
The ClinicalTrials.gov registry entry for NCT05085704 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (98% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Magnetic resonance imaging is the first listed.
NCT05085704 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05085704 about?
NCT05085704 is a clinical study titled "Brain Metabolism Observed at 7 Tesla". The goal is to develop methodology to monitor flux in the citric acid cycle in brain via 13C nuclear magnetic resonance (NMR) spectroscopy at 7 Tesla.
What is the current status of trial NCT05085704?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2022-05-03. Estimated completion is 2026-09-20.
What conditions does trial NCT05085704 study?
This clinical trial studies the following conditions: Epilepsy, Glucose Metabolism Disorders, Glut1 Deficiency Syndrome 1, Autosomal Recessive, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter Protein Type 1 Deficiency Syndrome.
What interventions are being tested in trial NCT05085704?
The interventions under investigation include: Magnetic resonance imaging (DEVICE).
Who is sponsoring clinical trial NCT05085704?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05085704 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.